Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

ASX Bank Shares
James Dunn

S&P/ASX 200 morning report, RBA hopes boost ASX 200

The Australian share market or S&P/ASX 200 (INDEXASX: XJO) opened Friday’s ASX trading session slightly higher. CBA shares and BHP shares were again a focus on share investors.

ASX tech shares
Lachlan Buur-Jensen

23 ASX share ideas for your 2023 watchlist

Get some top ASX share ideas for 2023. Wesfarmers Ltd (ASX:WES), Lovisa Ltd (ASX:LOV), TechnologyOne (ASX:TNE), CSL Ltd (ASX:CSL) and BHP Group Ltd (ASX:BHP) make this year’s list.

Skip to content